日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Differences in chronic kidney disease management based on identification and diagnosis in a population-based observational study

基于人群观察研究的慢性肾脏病管理差异:基于识别和诊断的差异

Olszewski, Michael; Bjurström, Karl; Lingman, Markus; Henrohn, Dan; Shojaiyan, Poyan; Garell, Magnus; Agvall, Björn

Vaccine Knowledge and Awareness Among Patients With Chronic Inflammatory Diseases: Results From a Nordic Survey

慢性炎症性疾病患者疫苗知识和意识:一项北欧调查的结果

Kapetanovic, Meliha; Mandla, Randeep; Gren, Susanne Thiesen; Seddighzadeh, Maria; Henrohn, Dan; Palmroth, Maaria; Hiltunen, Anna-Maria; Ranta, Jussi; Asikainen, Anna-Kaisa; Frøstrup, Anne Grete; Anttila, Veli-Jukka

A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol

一项基于泛欧洲注册登记的观察性研究,旨在评估阿布昔替尼与传统系统疗法在治疗中重度特应性皮炎中的疗效:DREAM TO TREAT AD 研究方案

Gribaleva, Elizaveta; Krogh, Niels Steen; Prieto-Merino, David; Coker, Bolaji; Jackson, Abaigeal; Akkoc, Ahmet; Birkner, Thomas; Bruninx, Erwin; Hennessy, Con; Chan, Kaitlyn; Cutlar, Lara; Farrell, Byron; Fletcher, Godfrey; Gerbens, Louise; Frostrup, Anne Grete; Henrohn, Dan; Hyseni, Ariënna; Irvine, Alan D; Malek, Rayka; McCarthy, Caitriona; Vittrup, Ida; Ouwerkerk, Wouter; Randall, Rowena; Spuls, Phyllis I; Thomsen, Simon Francis; Wall, Dmitri; Weidinger, Stephan; Werfel, Thomas; Schmitt, Jochen; Flohr, Carsten

Prospective observational study of tofacitinib in ulcerative colitis - analysis of clinical data, fatigue and health-related quality of life during the induction phase

托法替尼治疗溃疡性结肠炎的前瞻性观察研究——诱导期临床数据、疲劳和健康相关生活质量分析

Nyberg, Lisa; Halfvarson, Jonas; Söderling, Jonas; Olén, Ola; Strid, Hans; Hedin, Charlotte R H; Jónsdóttir, Sara B; Hjortswang, Henrik; Jäghult, Susanna; Cappelleri, Joseph C; Henrohn, Dan; Seddighzadeh, Maria; Marsal, Jan; Grip, Olof

Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs

在托法替尼临床开发项目中,类风湿性关节炎、溃疡性结肠炎或银屑病关节炎患者的流感不良事件

Winthrop, Kevin L; Yndestad, Arne; Henrohn, Dan; Danese, Silvio; Marsal, Sara; Galindo, Maria; Woolcott, John C; Jo, Hyejin; Kwok, Kenneth; Shapiro, Andrea B; Jones, Thomas V; Diehl, Annette; Su, Chinyu; Panés, Julian; Cohen, Stanley B

Care pathways in atopic dermatitis: a retrospective population-based cohort study

特应性皮炎的诊疗路径:一项基于人群的回顾性队列研究

von Kobyletzki, L; Ballardini, N; Henrohn, D; Neary, M P; Ortsäter, G; Geale, K; Rieem Dun, A; Lindberg, I; De Geer, A; Neregård, P; Cha, A; Cappelleri, J C; Romero, W; Thyssen, J P

Validation of Patient Identification Algorithms for Atopic Dermatitis Using Healthcare Databases

利用医疗保健数据库验证特应性皮炎患者识别算法

Ortsäter, Gustaf; De Geer, Anna; Geale, Kirk; Rieem Dun, Alexander; Lindberg, Ingrid; Thyssen, Jacob P; von Kobyletzki, Laura; Ballardini, Natalia; Henrohn, Dan; Neregård, Petra; Cha, Amy; Cappelleri, Joseph C; Neary, Maureen P

Age-based (<65 vs ≥65 years) incidence of infections and serious infections with tofacitinib versus biological DMARDs in rheumatoid arthritis clinical trials and the US Corrona RA registry

在类风湿关节炎临床试验和美国Corrona RA注册研究中,托法替尼与生物制剂DMARDs相比,按年龄(<65岁 vs ≥65岁)划分的感染和严重感染发生率。

Winthrop, Kevin L; Citera, Gustavo; Gold, David; Henrohn, Dan; Connell, Carol A; Shapiro, Andrea B; Shi, Harry; Onofrei, Alina M; Pappas, Dimitrios A; Schulze-Koops, Hendrik

Clinical and Economic Burden of Pediatric Mild-to-Moderate Atopic Dermatitis: A Population-Based Nested Case-Control Study in Sweden

瑞典一项基于人群的嵌套病例对照研究:儿童轻中度特应性皮炎的临床和经济负担

Ortsäter, Gustaf; Geale, Kirk; Dun, Alexander Rieem; Cappelleri, Joseph C; Cha, Amy; Romero, William; Henrohn, Dan; Neregard, Petra; Neary, Maureen P

Mycophenolate mofetil for systemic sclerosis: drug exposure exhibits considerable inter-individual variation-a prospective, observational study

吗替麦考酚酯治疗系统性硬化症:药物暴露量存在显著的个体差异——一项前瞻性观察研究

Andréasson, Kristofer; Neringer, Karl; Wuttge, Dirk M; Henrohn, Dan; Marsal, Jan; Hesselstrand, Roger